Cargando…
Antigen-Specific Polyclonal Cytotoxic T Lymphocytes Induced by Fusions of Dendritic Cells and Tumor Cells
The aim of cancer vaccines is induction of tumor-specific cytotoxic T lymphocytes (CTLs) that can reduce the tumor mass. Dendritic cells (DCs) are potent antigen-presenting cells and play a central role in the initiation and regulation of primary immune responses. Thus, DCs-based vaccination represe...
Autores principales: | Koido, Shigeo, Homma, Sadamu, Hara, Eiichi, Namiki, Yoshihisa, Ohkusa, Toshifumi, Gong, Jianlin, Tajiri, Hisao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850552/ https://www.ncbi.nlm.nih.gov/pubmed/20379390 http://dx.doi.org/10.1155/2010/752381 |
Ejemplares similares
-
Cancer Vaccine by Fusions of Dendritic and Cancer Cells
por: Koido, Shigeo, et al.
Publicado: (2009) -
Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions
por: Koido, Shigeo, et al.
Publicado: (2010) -
In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
por: Koido, Shigeo, et al.
Publicado: (2008) -
The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013) -
Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation
por: Koido, Shigeo, et al.
Publicado: (2013)